eBay Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? eBay Inc trades at $111.7 (market cap $47.88B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.24 (market cap $2.28B). The key difference: eBay Inc is far larger — about 21× SELLAS Life Sciences Group Inc. Common Stock's market cap, and eBay Inc pays a 1.15% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| EBAY | SLS | |
|---|---|---|
Market Cap | $47.88B | $2.28B |
Volume | 2,781,198 | 3,128,960 |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $15.46 |
52-Week Low | $79.41 | $1.39 |
Typical Hold Time | 134 Days | — |
Enterprise Value | $51.71B | $2.15B |
Dividend Yield | 1.15% | — |
Signals from Pluang's Aura AI — not financial advice
EBAY trades at $107.60, up 0.5% with a bullish technical signal and strong recent earnings beats. The company maintains robust profitability with 72% gross margins and 18.6% net income margin, though revenue growth remains moderate. Analyst consensus is positive with a $117.68 price target, representing 9% upside potential. Recent news highlights strategic focus on collectibles and live commerce while navigating competitive pressures from Amazon's multi-platform seller tools.
EBAY presents a balanced opportunity with strong fundamentals and analyst support, though faces execution risks in growth initiatives and competitive threats. The stock's current valuation appears reasonable given earnings consistency, but investors should monitor advertising growth trends and GameStop's strategic stake in the company.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →